SEC Form 4 · accession 0001162194-17-000044
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel D Colella
Director
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2017 | P | 7,500 | $5.925 | A | 17,500 | I | Colella Family Exempt Marital Deduction Trust dated 9/21/1992 |
| Common StockF1 | holding | — | — | — | 5,561 | I | Colella Family Partners, L.P | |
| Common Stock | holding | — | — | — | 43,523 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by Colella Family Partners, L.P. ("Colella Partners"). The shares were received in in-kind distributions by Versant Ventures I, LLC, which is the general partner of each of Versant Venture Capital I, L.P., Versant Side Fund I, L.P., Versant Affiliates Fund I-A, L.P. and Versant Affiliates Fund I-B, L.P. (collectively, the "Versant Funds"), on November 4, 2013. The Reporting Person is the General Partner of Colella Partners. The Reporting Person disclaims beneficial ownership of such shares held by Colella Partners, except to the extent of his proportionate pecuniary interest therein, if any.